QuickSilver Scientific is very excited to be able to offer Liposomal delivery of our broad-spectrum Biocidin® combination as specialized nutritional support. Physicians’ reports of reduction in pain and other symptoms in as little as 4-6 weeks of use have been very encouraging. University research continues with Biocidin® in addressing biofilm encapsulated infections. 

Lyme disease is on the rise, and in chronic Lyme disease and other neurological conditions, treatment is often more challenging, as pathogens can hide in the central nervous system or other fatty tissues, and may be part of a biofilm matrix. In Lyme, not only are the Borrelia burgdorferi spirochetes present, other co-infections such as Babesia are common. 

Key Benefits of Biocidin® LSF 

with Etheric Delivery™ 

• Assists in delivery of broad-spectrum botanicals to the central nervous system, a key benefit when addressing Lyme disease or other pathogens*
• Promotes intracellular absorption of ingredients*
• Enhances lymphatic circulation of therapeutic compounds*
• Unilamellar Vesicles have optimal particle size of 100 nanometers 
• Immediate bioavailability from oral cavity
• Assists in removal of biofilms*